Skeletal Consequences of Deletion of Steroid Receptor Coactivator-2/Transcription Intermediary Factor-2
Authors:
Open Access
- 1 July 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (28) , 18767-18777
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic womenOsteoporosis International, 2008
- The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out miceBone, 2008
- Protocol for the fast chromatin immunoprecipitation (ChIP) methodNature Protocols, 2006
- The Many Faces of PPARγCell, 2005
- SRC-1 Is Necessary for Skeletal Responses to Sex Hormones in Both Males and FemalesJournal of Bone and Mineral Research, 2004
- Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell linesJournal of Endocrinology, 2003
- Peroxisome Proliferator-activated Receptor γ Inhibits Transforming Growth Factor β-induced Connective Tissue Growth Factor Expression in Human Aortic Smooth Muscle Cells by Interfering with Smad3Journal of Biological Chemistry, 2001
- Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte MaturationJournal of Bone and Mineral Research, 1999
- Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγCell, 1998
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994